At the core of Vitalgenics is a series of regenerative products we call VitalMax Stem Cells. The VitalMax regenerative products are derived from umbilical cord blood and have been evaluated, tested, and certified by third-party labs for their safety and potency (see below). All the VitalMax regenerative products uphold the same level of quality with the only difference between them being the concentrations of stem cells contained therein.
We offer customized concentrations for specific regenerative therapies that give regenerative practitioners flexibility in procedures and costs. Our laboratory partner has been in the business of collecting, processing and storing umbilical cord blood for over two decades. You will be hard-pressed to find a higher quality product on the market, and as you know quality translates into results.
In many treatments, something called the engraftment potential is determinant on the number of viable cells that survive this reconstitution. Engraftment is the process by which the transplant recipient's tissues accept the product(s) and respond through cellular regeneration and repair. The reagents and methodologies our lab partner uses in the collection, processing, and preservation of these biologics enables VitalMax Stem Cells to boast the finest post-thaw cell recovery in the industry. This translates to increased engraftment potential and faster potential results.
A key success factor to superior cord blood processing is the removal of RBCs from the harvested umbilical blood. RBCs do not survive the cryopreservation and thawing process and their cell membranes rupture and introduce a host of contaminants to transplant administered. These contaminants cause illness. VitalMax Stem Cells have been shown to be 98.5% free of RBCs due to an advanced technique/reagent our laboratory partner uses called PREMIERMAX®. Safer transplants mean better patient results.
Every procedure performed on the biologics to produce VitalMax Stem Cells, from collection to cryopreservation, are approved and regulated by both the FDA and American Association of Blood Banks (AABB). Additionally, the Standards set forth by the National Marrow Donor Program (NMDP) are also strictly followed and every regulatory requirement exceeded. VitalMax Stem Cells undergo continual inspection which ensures we only provide the best.
SCREENING
Prior to our biologics even being collected, a complete donor medical history, physical and behavioral assessment, and an extensive set of serological tests are performed on the donor. This ensures the donor is a good candidate for the program, being free from disease and also exhibiting high standards of health. All of our collections are performed on donors delivering here within the USA.
COLLECTION
The umbilical cord blood collected is done so aseptically at the time of delivery from healthy pregnant women. Advanced cord blood collection bags containing the only FDA-approved anticoagulant (citrate phosphate dextrose) are always used which aide to increase cell yield and higher levels of treatment success. Harvested specimens are quickly transferred to one of many national processing labs.
PROCESSING
Processing only occurs on freshly collected cord blood that was harvested under aseptic and GMP standards, then further serological tests are performed. Utilizing PrepCyte-CB, the red blood cells, granulocytes, and other non-useful biologics are removed leaving only stem cells in the product. Final tests for growth, viability, and cell counts are performed prior to cryopreservation.
STORAGE
A key reagent called CryoStor® CS10 is used as the freeze media. This reagent is designed to protect cells at ultra-low temps and prevent intracellular ice. This added protection ensures higher cellular recovery & viability when it comes time for thawing. Cells are frozen at -1°C/minute in a -80°C freezer, and then transferred to liquid nitrogen where they are maintained for storage between -135°C and -160°C.
A team of scientists from the Cell Therapy Research Institute and the Newcastle Centre for Cord Blood published two separate studies that reached the same conclusion – our process is superior to hetastarch.
Simply put, the unbiased research team from the Cell Therapy Research Institute and the Newcastle Centre for Cord Blood also concluded that our process “is consistently the best performer over the whole range of analysis.” It provides the most efficient recovery, the highest red cell depletion, and reduces the risk for contamination.
Just like you, we wanted to know which process was the best. Having been in the industry since 1995, we have seen cord blood banking come a long way since the days of hetastarch, a first generation method. Over years of processing both public and private cord blood collections, we learned what worked best. We looked into clinical research that asked the same question. We found our answer in the US National Library of Medicine of the National Institute for Health.
Whether you are interested in exploring regenerative treatments for yourself, or you’re a Health Care Practitioner (HCP) and have questions… We are here to help. Simply click on the Get More Information button and an expert from our team will contact you to answer any questions you might have.